CC
BPMC
Casdin Capital’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-326,378
| Closed | -$28.9M | – | 34 |
|
|
2025
Q1 | $28.9M | Hold |
326,378
| – | – | 2.36% | 9 |
|
|
2024
Q4 | $28.5M | Hold |
326,378
| – | – | 1.89% | 14 |
|
|
2024
Q3 | $30.2M | Hold |
326,378
| – | – | 2.01% | 13 |
|
|
2024
Q2 | $35.2M | Hold |
326,378
| – | – | 2.69% | 11 |
|
|
2024
Q1 | $31M | Hold |
326,378
| – | – | 2.3% | 14 |
|
|
2023
Q4 | $30.1M | Sell |
326,378
-45,000
| -12% | -$4.15M | 2.96% | 12 |
|
|
2023
Q3 | $18.7M | Sell |
371,378
-248,622
| -40% | -$12.5M | 2.06% | 15 |
|
|
2023
Q2 | $39.2M | Sell |
620,000
-50,000
| -7% | -$3.16M | 3.42% | 11 |
|
|
2023
Q1 | $30.1M | Sell |
670,000
-807,800
| -55% | -$36.3M | 2.48% | 14 |
|
|
2022
Q4 | $64.7M | Sell |
1,477,800
-222,200
| -13% | -$9.73M | 5.02% | 6 |
|
|
2022
Q3 | $112M | Buy |
1,700,000
+550,000
| +48% | +$36.2M | 7.36% | 5 |
|
|
2022
Q2 | $58.1M | Sell |
1,150,000
-400,000
| -26% | -$20.2M | 4.91% | 6 |
|
|
2022
Q1 | $99M | Hold |
1,550,000
| – | – | 4.44% | 7 |
|
|
2021
Q4 | $166M | Hold |
1,550,000
| – | – | 4.68% | 6 |
|
|
2021
Q3 | $159M | Hold |
1,550,000
| – | – | 3.97% | 8 |
|
|
2021
Q2 | $136M | Hold |
1,550,000
| – | – | 3.46% | 8 |
|
|
2021
Q1 | $151M | Hold |
1,550,000
| – | – | 4.49% | 6 |
|
|
2020
Q4 | $174M | Hold |
1,550,000
| – | – | 5.15% | 5 |
|
|
2020
Q3 | $144M | Hold |
1,550,000
| – | – | 6.43% | 4 |
|
|
2020
Q2 | $121M | Hold |
1,550,000
| – | – | 7.15% | 2 |
|
|
2020
Q1 | $90.6M | Buy |
1,550,000
+610,000
| +65% | +$35.7M | 9.62% | 1 |
|
|
2019
Q4 | $75.3M | Hold |
940,000
| – | – | 6.92% | 4 |
|
|
2019
Q3 | $69.1M | Hold |
940,000
| – | – | 7.15% | 4 |
|
|
2019
Q2 | $88.7M | Buy |
940,000
+91,352
| +11% | +$8.62M | 8.3% | 3 |
|
|
2019
Q1 | $67.9M | Buy |
848,648
+208,648
| +33% | +$16.7M | 7.46% | 2 |
|
|
2018
Q4 | $34.5M | Sell |
640,000
-110,000
| -15% | -$5.93M | 5.9% | 3 |
|
|
2018
Q3 | $58.5M | Buy |
750,000
+115,000
| +18% | +$8.98M | 7.12% | 2 |
|
|
2018
Q2 | $40.3M | Buy |
635,000
+287,000
| +82% | +$18.2M | 5.64% | 3 |
|
|
2018
Q1 | $31.9M | Hold |
348,000
| – | – | 5.61% | 4 |
|
|
2017
Q4 | $26.2M | Buy |
348,000
+50,000
| +17% | +$3.77M | 6.39% | 4 |
|
|
2017
Q3 | $20.8M | Buy |
298,000
+23,000
| +8% | +$1.6M | 5.86% | 5 |
|
|
2017
Q2 | $13.9M | Sell |
275,000
-19,500
| -7% | -$988K | 5.15% | 4 |
|
|
2017
Q1 | $11.8M | Buy |
294,500
+50,000
| +20% | +$2M | 6.95% | 5 |
|
|
2016
Q4 | $6.86M | Sell |
244,500
-42,500
| -15% | -$1.19M | 5.66% | 6 |
|
|
2016
Q3 | $8.52M | Sell |
287,000
-53,000
| -16% | -$1.57M | 6.9% | 5 |
|
|
2016
Q2 | $6.89M | Buy |
340,000
+18,700
| +6% | +$379K | 6.85% | 6 |
|
|
2016
Q1 | $5.8M | Sell |
321,300
-91,200
| -22% | -$1.65M | 6.66% | 6 |
|
|
2015
Q4 | $10.9M | Buy |
+412,500
| New | +$10.9M | 9.6% | 1 |
|